Flexeril and Intervertebral disc degeneration - a phase IV clinical study of FDA data
Summary:
Intervertebral disc degeneration is reported as a side effect among people who take Flexeril (cyclobenzaprine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Pain.
The phase IV clinical study analyzes which people have Intervertebral disc degeneration when taking Flexeril. It is created by eHealthMe based on reports of 34,789 people who have side effects when taking Flexeril from the FDA, and is updated regularly.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.
What is Intervertebral disc degeneration?
Intervertebral disc degeneration (spinal disc degeneration) is found to be associated with 1,310 drugs and 1,500 conditions by eHealthMe. Check the latest studies of Intervertebral disc degeneration.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
34,789 people reported to have side effects when taking Flexeril.
Among them, 474 people (1.36%) have Intervertebral disc degeneration.
Among these 474 people:
How long have people been on Flexeril when they have Intervertebral disc degeneration? *
What is the gender of people who have Intervertebral disc degeneration when taking Flexeril? *
What is the age of people who have Intervertebral disc degeneration when taking Flexeril? *
What are other drugs people take besides Flexeril? *
What are other side effects people have besides Intervertebral disc degeneration? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Flexeril and have Intervertebral disc degeneration?
- Check whether Intervertebral disc degeneration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Flexeril:
- Flexeril (38,308 reports)
Intervertebral disc degeneration treatments and more:
- Intervertebral disc degeneration (19,910 reports)
How severe was Intervertebral disc degeneration and when was it recovered:
Expand to all the drugs that have ingredients of cyclobenzaprine hydrochloride:
- Intervertebral disc degeneration and drugs with ingredients of cyclobenzaprine hydrochloride (822 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Intervertebral disc degeneration:
- Intervertebral disc degeneration (1,310 drugs)
Browse all the conditions that are associated with Intervertebral disc degeneration:
- Intervertebral disc degeneration (1,500 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride (the active ingredients of Flexeril) and Flexeril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Olanzapine cause Rickets? - 3 seconds ago
- Could Ayvakit cause Weight Decreased? - 6 seconds ago
- Could Plavix cause Itching? - 10 seconds ago
- Drug interactions of Lopressor and Topamax - 14 seconds ago
- Drug interactions of Estradiol and Evening Primrose - 16 seconds ago
- Could Fluorouracil cause Bicytopenia? - 22 seconds ago
- Could Ranitidine Hydrochloride cause Non-Hodgkin'S Lymphoma? - 26 seconds ago
- Could Thiamine cause Mental Disorder? - 29 seconds ago
- Could Vitamin C cause Blood Phosphorus Increased? - 36 seconds ago
- Could Evista cause Periodontal Disease? - 39 seconds ago